Masashi Kobayashi

Mr. Masashi Kobayashi


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
MKMasashi Kobayashi
Masashi Kobayashi
Takashiro AkitsuTakashiro Akitsu
Takashiro Akitsu
Masahiro FuruyaMasahiro Furuya
Masahiro Furuya
TSTetsushi Sekiguchi
Tetsushi Sekiguchi
SSShuichi Shoji
Shuichi Shoji
DTDaiki Tanaka
Daiki Tanaka
The efficient synthesis of amino acid Schiff base copper(II) complexes using a microfluidic device was successfully achieved. Schiff bases and their complexes are remarkable compounds due to their high biological activity and catalytic function. Conventionally, products are synthesized under reaction conditions of 40 °C for 4 h using a beaker-based method. However, in this paper, we propose using a microfluidic channel to enable quasi-instantaneous synthesis at room temperature (23 °C). The products were characterized using UV–Vis, FT–IR, and MS spectroscopy. The efficient generation of compounds using microfluidic channels has the potential to significantly contribute to the efficiency of drug discovery and material development due to high reactivity.

22 March 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
SSSeito Shijo
Seito Shijo
DTDaiki Tanaka
Daiki Tanaka
TSTetsushi Sekiguchi
Tetsushi Sekiguchi
JIJun-Ichi Ishihara
Jun-Ichi Ishihara
HTHiroki Takahashi
Hiroki Takahashi
SSShuichi Shoji
Shuichi Shoji
We developed a microfluidic device that enables selective droplet extraction from multiple droplet-trapping pockets based on dielectrophoresis. The device consists of a main microchannel, five droplet-trapping pockets with side channels, and drive electrode pairs appropriately located around the trapping pockets. Agarose droplets capable of encapsulating biological samples were successfully trapped in the trapping pockets due to the difference in flow resistance between the main and side channels. Target droplets were selectively extracted from the pockets by the dielectrophoretic force generated between the electrodes under an applied voltage of 500 V. During their extraction from the trapping pockets, the droplets and their contents were exposed to an electric field for 400–800 ms. To evaluate whether the applied voltage could potentially damage the biological samples, the growth rates of Escherichia coli cells in the droplets, with and without a voltage applied, were compared. No significant difference in the growth rate was observed. The developed device enables the screening of encapsulated single cells and the selective extraction of target droplets.

11 May 2023 in Micromachines
Verified
Journal Article
Open access
PDF file
DTDaiki Tanaka
Daiki Tanaka
JIJunichi Ishihara
Junichi Ishihara
HTHiroki Takahashi
Hiroki Takahashi
MKMasashi Kobayashi
Masashi Kobayashi
AMAya Miyazaki
Aya Miyazaki
SSShuichi Shoji
Shuichi Shoji
In this study, we developed a comb-shaped microfluidic device that can efficiently trap and culture a single cell (bacterium). Conventional culture devices have difficulty in trapping a single bacterium and often use a centrifuge to push the bacterium into the channel. The device developed in this study can store bacteria in almost all growth channels using the flowing fluid. In addition, chemical replacement can be performed in a few seconds, making this device suitable for culture experiments with resistant bacteria. The storage efficiency of microbeads that mimic bacteria was significantly improved from 0.2% to 84%. We used simulations to investigate the pressure loss in the growth channel. The pressure in the growth channel of the conventional device was more than 1400 PaG, whereas that of the new device was less than 400 PaG. Our microfluidic device was easily fabricated by a soft microelectromechanical systems method. The device was highly versatile and can be applied to various bacteria, such as Salmonella enterica serovar Typhimurium and Staphylococcus aureus.